Position in NVO
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,176,735
+$545,628 QoQ
Shares Held
24,546
+42.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#492
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Manske Wealth Management holds $11,013,103 across 10 Drug Manufacturers - General names. NVO ranks #5 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
15,455 | $1,985,967 | |
| 2 | GSK |
GSK plc
|
37,767 | $1,979,746 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
23,392 | $1,347,847 | |
| 4 | PFE |
Pfizer Inc
|
53,019 | $1,276,697 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
24,546 | $1,176,735 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,591 | $1,085,386 | |
| 7 | LLY |
ELI LILLY & Co
|
549 | $658,487 | |
| 8 | JNJ |
Johnson & Johnson
|
2,186 | $555,178 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,176,735 | 24,546 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $631,107 | 17,173 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $248,294 | 4,880 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||